BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 603630)

  • 1. Purification and properties of the hexosaminidase A-activating protein from human liver.
    Hechtman P; LeBlanc D
    Biochem J; 1977 Dec; 167(3):693-701. PubMed ID: 603630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.
    Hechtman P
    Can J Biochem; 1977 Apr; 55(4):315-24. PubMed ID: 858083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.
    Hechtman P; Kachra Z
    Biochem J; 1980 Mar; 185(3):583-91. PubMed ID: 7387624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
    Hechtman P; Gordon BA; Ng Ying Kin NM
    Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate binding properties of the human liver hexosaminidase A activator protein.
    Hechtman P; Isaacs C; Smith-Jones L
    Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species.
    Burg J; Banerjee A; Conzelmann E; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):821-9. PubMed ID: 6225718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
    Hirabayashi Y; Li YT; Li SC
    J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.
    Kytzia HJ; Sandhoff K
    J Biol Chem; 1985 Jun; 260(12):7568-72. PubMed ID: 3158659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation and characteristics of hexosaminidase A and activator protein from human kidney].
    Aronovich EL; Akhunov VS; Krasnopol'skaia KD
    Biokhimiia; 1990 Jan; 55(1):43-51. PubMed ID: 2140519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.
    Conzelmann E; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1837-49. PubMed ID: 527942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
    Conzelmann E; Burg J; Stephan G; Sandhoff K
    Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM2 ganglioside activator occurs in multiple forms.
    Novak A; Lowden JA
    Biochim Biophys Acta; 1994 Mar; 1199(2):209-14. PubMed ID: 8123670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A.
    Yadao F; Hechtman P; Kaplan F
    Biochim Biophys Acta; 1997 Jun; 1340(1):45-52. PubMed ID: 9217013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of an activator protein for the hydrolysis of ganglioside GM2 from the roe of striped mullet (Mugil cephalus).
    DeGasperi R; Li YT; Li SC
    Biochem J; 1989 Jun; 260(3):777-83. PubMed ID: 2527497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A.
    Hou Y; Tse R; Mahuran DJ
    Biochemistry; 1996 Apr; 35(13):3963-9. PubMed ID: 8672428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E; Sandhoff K
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Purification and characterization of cerebroside sulfatase activator].
    Mitsuyama T
    Hokkaido Igaku Zasshi; 1983 Sep; 58(5):502-12. PubMed ID: 6141130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A.
    Xie B; Rigat B; Smiljanic-Georgijev N; Deng H; Mahuran D
    Biochemistry; 1998 Jan; 37(3):814-21. PubMed ID: 9454570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine.
    Li YT; Mazzotta MY; Wan CC; Orth R; Li SC
    J Biol Chem; 1973 Nov; 248(21):7512-5. PubMed ID: 4745777
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of human hepatic H-acetyl-beta-D-hexosaminidose. A activity toward natural glycosphingolipid substrates.
    Bach G; Suzuki K
    J Biol Chem; 1975 Feb; 250(4):1328-32. PubMed ID: 1112809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.